港股異動|中梁控股大升超15% 股價創逾一個月新高
中梁控股(2772.HK)午後進一步拉昇,一度大升15.58%至0.089港元,股價創5月30日以來逾一個月新高。中梁控股昨日晚間公吿,於2025年1月至6月,集團累計合約銷售(連合營企業及聯營公司的合約銷售)金額約63.8億元(人民幣,下同),累計合約銷售面積約596,000平方米。1月至6月合約銷售均價約10,700元/平方米。於2025年6月,集團合約銷售(連合營企業及聯營公司的合約銷售)金額約10.1億元,合約銷售面積約95,000平方米。集團2025年6月合約銷售均價約10,600元/平方米。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.